Trial · NCT03500159
Outcomes15
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline to Week 12 in Maximum Daily Pelvic Pain (Mean) | 12 Weeks | Study was terminated prematurely, no analysis was performed | ||
| SECONDARY | Change From Baseline to Week 12 in NIH-CPSI | 12 Weeks | |||
| SECONDARY | Change From Baseline to Week 12 in IIEF-EF | 12 Weeks | |||
| SECONDARY | Change From Baseline to Week 12 in Average Daily Pelvic Pain (eDiary), | 12 Weeks | |||
| SECONDARY | Change From Baseline to Week 12 in Average and Maximum Pelvic Pain Scores in Clinic | 12 Weeks | |||
| SECONDARY | Change From Baseline to Week 12 in 24-hour Voiding Frequency (eDiary) | 12 Weeks | |||
| SECONDARY | Time Course of Effects From Baseline Through to Week 16: AQX-1125 200 mg Compared to Placebo for Each of the Pain and Symptom Scale Endpoints | 16 Weeks | |||
| SECONDARY | Response to Treatment Compared to Placebo at Week 12 as Measured by the GRA | 12 Weeks | |||
| SECONDARY | Response to Treatment Compared to Placebo at Week 12 as Measured by the PGI-C | 12 Weeks | |||
| SECONDARY | Response to Treatment Compared to Placebo at Week 12 as Measured by the PGI-S | 12 Weeks | |||
| SECONDARY | The Proportion of Subjects With ≥30% and ≥50% Improvement in Maximum Daily Pelvic Pain Compared to Placebo | 12 Weeks | |||
| SECONDARY | The Proportion of Subjects With ≥30% and ≥50% Improvement in NIH-CPSI Pain Subscale Compared to Placebo | 12 Weeks | |||
| SECONDARY | Response to Treatment | 12 Weeks | |||
| SECONDARY | Discontinuation of Study Medication Due to Treatment Failure | 12 Weeks | |||
| SECONDARY | Frequency and Severity of Adverse Events (AEs) | 12 Weeks |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03500159/outcomes